We use cookies to provide you with a better service. Carry on browsing if you’re happy with this or read more about our cookie policy and privacy policy.
by Victoria Gaunt
Chemical Pathology
by Sarah Simmons & Katy Murphy
As with most tumour markers there is a high incidence of false positive and false negative results. CA 19-9 is most appropriately used in monitoring disease progression or effectiveness of treatment once diagnosis of the tumour has been made and serum concentrations have been shown to be raised prior to treatment (Lewis negative individuals do not express CA 19-9).
by Lisa Jones
Feeding is so much more than just provision of nutrients, it will help build relationship with your baby and help you learn their communication cues.
This page provides information for women and birthing people who have been identified as being at risk of having a preterm (premature) birth. We hope that this information will help you to understand the risk factors and how the Preterm Birth team will support you during pregnancy to try to reduce the risk.
Staff across Gloucestershire Hospitals can now benefit from a brand-new Workplace Health Check Service. The specialist wellbeing nurse role, funded thanks to your donations, has been designed to help support physical wellbeing.
by Jade Edwards
Determined fundraisers who have experienced baby loss are going the extra mile to help create a new remembrance garden at Gloucestershire Royal Hospital.
Feeding is so much more than just provision of nutrients, it will help build a relationship and bond with your baby. This page aims to explain the feeding journey your baby might have when they go home from the neonatal unit.
NHS Stroke services Gloucestershire
A Medical Ophthalmologist from Gloucestershire Hospitals NHS Foundation Trust has been named as a finalist at the prestigious Royal College of Physicians’ (RCP) Excellence in Patient Care Awards.
Two-year-old Connie Billingham never met her grandma Gill, but she will be joining her Mum to walk in her memory at a special charity event later this year.
This page has been written to give you information about a medicine called magnesium sulphate. Magnesium sulphate (MgS04) is a medicine offered to women whose baby will be born between 24 and 30 weeks of pregnancy. This is because we know that it can protect some babies from developing cerebral palsy. You will have been referred this page to read because either a decision has been made by the doctor that your baby needs to be born early, or you have gone into premature labour and it is believed that having the magnesium sulphate would be of benefit to you and your unborn baby.
